Proinflammatory cytokines such as leukemia inhibitory factor (LIF) and IL-6, released by both cancer cells and CAFs, contribute to the epigenetic modification of CAFs, leading to enhanced protumorigenic function by remodeling of the extracellular matrix. This evidence concerns the gene LIF and cancer.